Tourism isn’t the only industry eager to benefit from the relaxing of the decades-long trade embargo against Cuba. Medical researchers on both of sides of the Straits of Florida now have the chance to collaborate with previously off-limits colleagues. Of particular interest to the U.S. is a Cuban lung cancer drug that took 25 years to develop. Read more…

View article:
The US Is Finally Getting Access to a Promising Cancer Drug From Cuba